TEV Report
TEV Report
TEV Report
PROJECT AT A GLANCE
Particulars Description
1. Name M/S. Medi Mart India Private Limited.
2. Constitution Private Limited Company
3. Date of incorporation 08-10-2008
4. Office Flat No.302 & 303, Classic Court Apartments
Erramanzil, Hyderabad – 500 082.
6. Line of Activity To set up Retail Outlets of Pharmaceuticals
d) B.E.P. : 65.60 %
e) I.R.R. : 24.76 %
1
M/S. Medi Mart India Private Limited.
State Bank of Hyderabad, Secretariat Branch, Hyderabad, has entrusted us the task of Conducting
Techno Economic Viability study of M/S. Medi Mart India Pvt Ltd., who have approached
them for financial assistance.
We have discussed the contents of the report with the promoters who have confirmed that it does
not contain any material error or fact of omission and fairly set out the state of affairs.
The projections contained in the report are estimates and represent only one possible result
depending upon the assumptions made. Further the projections and the underlying assumptions
may vary depending upon evolving circumstances. There is no representation or assurance that the
new development will achieve the results indicated in the projections as the assumptions upon
which they were based are inherently subject to uncertainty and variation depending upon
evolving events. However, the projections have been conscientiously prepared, based on the
discussions and knowledge of the market and the information supplied to us.
2
M/S. Medi Mart India Private Limited.
INTRODUCTION
M/s. Medi Mart India Private Limited is a private limited company incorporated on 08-10-
2008 by a group of people with diverse backgrounds and experience with a mission to establish a
successful chain of genuine, friendly neighborhood drugstores in South India. After all necessary
clearances and full fledged infrastructure setup, its first store was launched in April 2009 at
V.V.Nagar, Kukatpalli, Hyderabad. As on July 2009, Medimart presently operates 20 stores
across Hyderabad, and proposes to open 350 stores in south India by the end of 2014. Professional
and passionate to the core, the company is moving fast forward into the future.
The main objects of the Company are as follows:
3
M/S. Medi Mart India Private Limited.
The Indian pharmaceutical market is the world’s 13th largest in terms of value and the 4th largest
in terms of volume. The total market size is US $ 5.7 bn (Ref: IMS Health) and includes all the
pharmaceutical products, fast moving healthcare products and some FMCG products sold through
the chemists across the country.
While all the formats of retailing have changed, be it apparel retailing, grocery retailing, fuel
retailing or jewellery retailing, somehow pharmacy retailing has not undergone changes. The
changes in the next 5 years in this business will be more than what has happened in the past 55
years. Earlier shopping was considered a headache involving running from pillar to post. Now
retailing has changed it to leisure and pleasure & it’s become more of an outing for the entire
family.
Pharmacy retailing has seen consolidation world over. 5 pharmacy chains control 40% of the sales
in the US. 7 pharmacy chains control more than 60% of the market in UK. A similar situation
prevails in most developed nations around the world.
This is a need driven business and every family requires medicines / health related goods. So the
scope of educated people getting into the same is higher. Margins are decent and returns are good.
Doctors are getting into this business. An average family spends 20% of its monthly wallet spend
on health care, up from 10% in 1985.
Pharmaceutical Retail just got an image makeover. Much like the beauty products hitherto sold off
dusty shelves promised, it’s a whole new look. For one, new pharmacy stores boast of excellent in
store display. But that’s cosmetic. What is intrinsic is that they also promise better quality,
ambience, convenience and prices. So Indian customers fed-up and resigned to spurious, expired
or poorly stored drugs are offered an option. The pharmacy retail sector is set for a shakeup and
consolidation with many organized players investing long term in it.
4
M/S. Medi Mart India Private Limited.
Some of the change is driven by market characterized by low entry barriers and capital
requirements. It’s a highly lucrative market with high margins that require low investment. The
Rs.48, 000–crore Indian pharmacy sector is dominated by the highly fragmented, unorganized
players, constituting mainly the neighborhood chemist that sells medicines and OTC drugs along
with other medical equipments and accessories.
There are currently over 8, 00,000 medical shops serving the Indian market. Trade associations
and experts opine that nearly 97 – 99% is dominated by unorganized sector. This is high
penetration compared to other similar countries. Number of local pharmacies in India is more than
that of US, Europe and China put together for a pharmaceutical market size which is less than a
percentage of their combined market. When we compare with China, which has approximately 2
lakh outlets for a domestic market of $15 billion, the Indian Pharma retail with approximately 5.5
lakh retailers for $6 billion market appears highly over-proliferated. However the business and the
landscape are changing. There are other serious regulatory and supervisory hurdles to be crossed
before the country can really leverage the benefits of high penetration of medical shops.
1. Prevalence of spurious or counterfeit drugs is high with estimates ranging from 5% to
30% of the market.
2. Standalone medical shops are able to avoid sales tax, this being a cash business
offering fake bills to regular customers.
3. The drugs are stored in sub-optimal store conditions in most places, making the
efficacy of the medicines questionable.
In such a scenario, customers are patronising reputed chains wherever they operate. The organised
pharmacy retail is growing at 100 % per year. Last year, chains like Medicine Shoppe grew almost
by 100%.
With internet being used at a much lower level in India, internet pharmacies may be the order of
the day 5 to 10 years from now. This is going to bring about a big change in the customer’s
perception, cost and service levels in pharmacy retailing.
5
M/S. Medi Mart India Private Limited.
With India becoming a major destination for medical tourism, the retail medicine business cannot
remain unaffected. It has to change and adopt global standards. While India can be considered as a
developed country for IT, Health care and Pharma are still looked upon as developing areas.
How will change happen? Corporates and organized pharmacies will have to drive the change like
Apollo did in 1987 and the ‘Dial for Health’ initiative by the Zydus group. The future of
pharmacy retailing is in for a big shakeout from all the three stakeholders; manufacturers, retailers
and customers Since all are looking at a better value for saving time, costs and delivering a better
value with fast and relevant information, there could not be a better time for the changes in
pharmacy retail
The pharmacy market is growing at 27% annually and revenue from pharmacies is expected to
touch 50,000-crore by 2010. Other experts like murlidharan Nair of Ernst & young say that the
sector is growing at 15% and will double its size in the next 5 years.
6
M/S. Medi Mart India Private Limited.
Apollo Pharmacy:
Apollo Pharmacy, a division of Apollo hospitals enterprises ltd., is India’s largest branded
pharmacy network with over 700 outlets in key locations across 17 states. The pharmacy business
of Apollo is growing at a phenomenal rate of 70% with revenues of Rs.600 crore achieved last
year. The chain has served over one crore customers ever since they started their first store in the
year1983.
Hetero Pharmacy:
Hetero Group launched its retail pharmacy chain hetero pharmacy in Hyderabad in the first
quarter of 2008. Presently they have grown to 100 stores in 12 months, with 75 stores in
Hyderabad and the rest in various cities and towns in Andhra Pradesh. Hetero plans to establish
1000 pharmacy stores by 2011 all over India.
7
M/S. Medi Mart India Private Limited.
MISSION
8
M/S. Medi Mart India Private Limited.
The promoters/ the subscribers to the memorandum of the Company are Mr. R.Reddeppa Reddy
and Ms. N.Bharathi. Sensing the potentials of the retail pharmacy in India, have floated a
company by name M/s. Medi Mart Private Limited to set up retail outlets of pharmaceuticals.
R.Reddeppa Reddy: S/o Sidda Rami Reddy, R/o H.No.08-01-301/41, Laxmi Nagar Colony,
Shaikpetnala, Hyderabad – 500 008.He is aged about 45 years. He is a consultant
anaesthesiologist in medicity hospitals.
Mrs. N.Bharathi: W/o N.Krishna Reddy, R/o H.No.08-01-301/41, Laxmi Nagar Colony,
Shaikpetnala, Hyderabad – 500 008. She is aged about 55 years. She is a house wife.
9
M/S. Medi Mart India Private Limited.
Mr.D.SudhakarReddy.
Chairman
Mr.Devireddy Sudhakar Reddy is the Managing Director of DSR Infrastructure Pvt. Ltd., one of
the fastest growing Construction companies headquartered in Hyderabad with operations in
Hyderabad and Bangalore. He has over 20 years of varied experience and has carved a separate
`position for himself in the real estate sector and commands a healthy respect in the industry.
Today he is at the helm of affairs, with a highly focused vision. He has been the source of
inspiration for and reason behind the astronomical rise of DSR Group. At Medimart, he provides
hands-on leadership to the Planning and implementation of company's finance, accounting and
generation of high quality reports for decision making.
Today, He is back with Medimart Pharmacy. His previous experience with retail Pharma business
and his present professional experience have helped him gain enormous amount of understanding
in the field of Pharma retailing. Mr. Reddy wants to bring in professionalism to an otherwise
unorganized retail Pharma industry. He is responsible for devising business development
strategies, forging strategic alliances, establishing high level contacts in the industry, recruiting
and purchase of genuine medicines from authorized stockiest and distributors.
10
M/S. Medi Mart India Private Limited.
Mr.P.Chaitanya
Executive Director
Mrs.N.Bharathi
W/o N.Krishna Reddy, R/o H.No.08-01-301/41, Laxmi Nagar Colony, Shaikpetnala, Hyderabad –
500 008. She is aged about 55 years. She is a house wife.
Mr.D.Prabhakar Reddy
S/o Late D.Subba Rami Reddy, R/o H.No.455/1, Road No-19, Jubilee Hills, Hyderabad – 500
033. He is aged about 51 years.
11
M/S. Medi Mart India Private Limited.
Following are companies /firms with which the directors are associated:
M/s. DSR Infrastructure Pvt Ltd: is a private limited company in which Mr.D.Sudhakar Reddy,
Mr.D.Prabhakar Reddy and Mr.P.Chaitanya are the directors. The Company is engaged in the
Construction activity.
12
M/S. Medi Mart India Private Limited.
M/s. Sri Sreenivasa Constructions: is a Partnership firm in which Mr.D.Sudhakar Reddy and
Mr.D.Prabhakar Reddy are one of the partners of the firm. The firm is engaged in real estate by
constructing and sale of flats.
M/s. D S R Builders & Developers: is a Partnership firm in which Mr.D.Sudhakar Reddy is one
of the partners of the firm. The firm is engaged in real estate by constructing and sale of flats.
13
M/S. Medi Mart India Private Limited.
M/s. Medi Mart India Private Limited is a company to do the Business of Marketing in
Medicines, Drugs, Pharmaceuticals, Cosmetics, Surgicals, Medical Instruments and
Equipments in whole sale, Retail, and to set up chain stores, Marketing outlets, clinics and
Laboratories.
To Carry on the business of Manufacturing, buying, selling or otherwise deal in drugs,
Pharmaceuticals, Medicines, Surgicals, Lab Equipments, Bio-chemicals, Organic and
inorganic Chemicals, biological products, diagnostic agents, immunological agents,
veterinary products, Animal foods, Cosmetics, Fine Chemicals, Dyes and Intermediates,
and all kids of by Products thereof.
To Export, Import, Manufacture, Purchase or Prepare for market and generally deal in
merchandised of every kind and description used in Pharmaceutical, Medical, Surgical,
Diagnostic and Drug Industry.
14
M/S. Medi Mart India Private Limited.
Presently, Medimart has presence in 35 various locations across Hyderabad city. Medimart Plans
to open 65 more stores in Andhra Pradesh by the end of second quarter of 2010-11.So that the
total out lets become 100 nos.
Some of the strategic locations planned for Hyderabad are:
15
M/S. Medi Mart India Private Limited.
Particulars Rs lakhs
Furniture & Fixtures 133.00
Interiors 119.00
Computers & Software 79.00
Vehicles 11.00
Other Assets 67.00
Rent Deposits (1 lack per shop) 105.00
Preliminary & Pre operative Expenses 109.00
Working Capital Margin 127.00
Total 750.00
MEANS OF FINANCE:
Particulars Rs lakhs
Promoters Contribution 200.00
Term Loan 250.00
Unsecured Loans from Promoters 300.00
Total 750.00
16
M/S. Medi Mart India Private Limited.
17
M/S. Medi Mart India Private Limited.
UTILITIES
MEDICINES
Medimart purchases all its medicines from authorised distributors and stockists directly without
having to deal with middlemen. This exercise helps in eliminating the middlemen and also
procuring the material directly at much better margins and quality guarantee.
MAN POWER
Medimart already has 190 plus employee strength and is growing steadily. The strength of the
company lies with the employees and Medimart has been successful in finding the best talent
available for its operations. Medimart employs totally 4 personnel for each store. They are 3
pharmacy aides and 1 Pharmacist. Apart from the store, they employ marketing executives,
projects personnel, and ware house staff on a regular basis.
18
M/S. Medi Mart India Private Limited.
MARKETING ASPECT
The Visibility of the store plays an important role in generating more business. Medimart stores
are strategically located with good visibility and income generating locations. The interiors play
an important role in drawing customers inside the store. The Interiors have been planned and
designed by a leading architect who has been successful in giving them the best designs in retail
pharmacy chain store. All are air-conditioned stores with hygiene as the top priority. The company
wants to give different retail experience to customers
Call centre:
Medimart has been successful in getting a fancy call centre number which is easy to remember at
all times. The customer can call on 040-23 44 44 44 for any kind of queries including deliveries
between 7:00am to 11:00Pm. Free home delivery is offered to any customer within city limits.
The dedicated call centre staff calls up the existing customers on a regular basis to find out their
medicine requirements and intimates them the latest offers available. Medimart has developed
unique call centre software to facilitate the company to send out bulk sms to all its customers
regarding its monthly offers.
19
M/S. Medi Mart India Private Limited.
20
M/S. Medi Mart India Private Limited.
SWOT ANALYSIS
Strengths:
Dr.R.Reddeppa Reddy is a consultant Anesthesiologist, is having good contacts
with various hospitals and having knowledge in pharmacy trade.
Weaknesses:
Any increase in the cost of Medicines has an impact on the selling price of
the product
Opportunities:
Threats:
Competition from other existing players, which may have effect on selling price
of the medicines.
21
M/S. Medi Mart India Private Limited.
SCHEDULE OF IMPLEMENTATION
The Schedule provided below is based upon the project continuing in a logical sequence without
interruption of implementation.
Accordingly the schedule of the setting up of shops is as follows.
No. of Shops
Year Month
Commenced
2009-10 April 0
May 8
June 13
July 15
August 18
September 19
October 19
November 22
December 35
January 40
February 50
March 60
2010-11 April 67
May 74
June 81
July 88
August 95
September 100
22
M/S. Medi Mart India Private Limited.
SUMMARY OF OBSERVATIONS
The above analysis indicates that the scheme is viable and can withstand adverse change in
cost of Medicines and Selling price to an extent of 2%.
23
M/S. Medi Mart India Private Limited.
1. An increase of 5% per annum is considered in salaries, repairs and maintenance and other
administrative expenses from the third year onwards.
4. Interest on term loan @ 14.25 % and on working capital worked out at 14.25 %
7. During 2009-10, 20% margin is considered on sales as the cost of Medicines, and 17%
margin is considered from 2010-11 onwards as credit period allowed by the suppliers.
9. Unsecured loans from the shareholders considered as interest free and interest not charged.
The various items of expenditure and income as considered in the projections are based on the
prevailing trends in the trade industry.
24